UNSPSC 51183513: Phenformin hydrochloride

This classification denotes an anti-diabetic agent with the molecular formula C10H15N5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 91XC93EU03, chemically known as imidodicarbonimidic diamide, n- (2-phenylethyl)-, monohydrochloride but more generally known as phenformin hydrochloride, which bears US NIH Compound Identifier 8249. European Medicines Agency schedules Phenformin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03743MIG.

Most nations, for tariff and trade purposes, schedule phenformin hydrochloride under HS 29252900 and SITC 51482. As of Q4 2014, PHENFORMIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Phenformin hydrochloride bears US NLM identifiers UMLS ID C0770237 and NCI Concept Code C81696. SMILES: C1CCC(CC1)CCNC(=N)NC(=N)N.CL.

UNSPSC 51183513 Phenformin hydrochloride, a Commodity code, covers the procurement of this antidiabetic pharmaceutical agent by state and local health departments, correctional facilities, and public healthcare systems. Phenformin hydrochloride is a biguanide compound used historically in diabetes management, though its availability and use patterns vary by jurisdiction and clinical protocol. State and local governments procure this drug through health system formularies, pharmacy benefit management agreements, and direct purchase orders from pharmaceutical distributors. Issuing bodies include state departments of health, county health departments, municipal public hospitals, state correctional systems, and independent healthcare provider networks operated by or contracted to local jurisdictions.

The source provides no recent state or local contract opportunities tagged under this code, indicating either minimal procurement activity or infrequent solicitation in the monitored public records. Without posted RFP, RFQ, IFB, or ITB notices, geographic concentration and current market demand cannot be assessed from available data. Businesses pursuing phenformin hydrochloride supply should monitor state pharmaceutical procurement channels, state health department formulary updates, and correctional system supply contracts, as these venues do not always post opportunities under commodity-specific UNSPSC codes but may instead use blanket pharmaceutical distribution or group purchasing organization agreements.